Zimmer Biomet (NYSE: ZBH) director adds phantom stock units in deferred award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
HAGEMANN ROBERT reported acquisition or exercise transactions in this Form 4 filing.
Zimmer Biomet Holdings, Inc. director Robert Hagemann reported receiving a grant of 308.711 Phantom Stock Units on March 31, 2026. These units are tied 1-for-1 to the company’s common stock value and increase his deferred balance to 31,982.841 units.
The units were accrued under Zimmer Biomet’s Deferred Compensation Plan for Non-Employee Directors and will be settled in cash in five annual installments after his board service ends. His balance also includes 87.178 phantom units added earlier under the plan’s dividend reinvestment provision.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
HAGEMANN ROBERT
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock Units | 308.711 | $0.00 | -- |
Holdings After Transaction:
Phantom Stock Units — 31,982.841 shares (Direct)
Footnotes (1)
- The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. The Conversion or Exercise Price of Derivative Security is 1-for-1. Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Includes 87.178 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Key Figures
Phantom units granted: 308.711 units
Total phantom units after grant: 31,982.841 units
Dividend reinvestment units: 87.178 units
+2 more
5 metrics
Phantom units granted
308.711 units
Grant on March 31, 2026 to director Robert Hagemann
Total phantom units after grant
31,982.841 units
Deferred compensation balance following the March 31, 2026 award
Dividend reinvestment units
87.178 units
Accrued on January 30, 2026 under dividend reinvestment provision
Conversion ratio
1-for-1
Phantom Stock Units track Zimmer Biomet common stock value
Installment count
5 annual installments
Cash settlement schedule after end of director’s service year
Key Terms
Phantom Stock Units, Deferred Compensation Plan for Non-Employee Directors, dividend reinvestment provision, settled in cash
4 terms
Phantom Stock Units financial
"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."
Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.
Deferred Compensation Plan for Non-Employee Directors financial
"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."
dividend reinvestment provision financial
"Includes 87.178 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."
A dividend reinvestment provision is a company policy that lets shareholders automatically use their cash dividends to buy more shares instead of receiving money. Think of it like a subscription that turns each payday into buying an extra slice of the same pie; it helps investors compound their holdings over time, often with lower transaction costs and sometimes at a small discount, which can boost long‑term returns and subtly change ownership percentages.
settled in cash financial
"Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs."
FAQ
What insider transaction did ZIMMER BIOMET (ZBH) director Robert Hagemann report?
Robert Hagemann reported receiving 308.711 Phantom Stock Units on March 31, 2026. These derivative units track Zimmer Biomet common stock value and were granted under the Deferred Compensation Plan for Non-Employee Directors as a compensation-related award, not an open-market purchase or sale.
What are Phantom Stock Units in the ZIMMER BIOMET (ZBH) Form 4 filing?
Phantom Stock Units are derivative awards whose value mirrors Zimmer Biomet common stock on a 1-for-1 basis. They are accrued under the company’s Deferred Compensation Plan for Non-Employee Directors and are ultimately settled in cash rather than delivering actual common shares to the director.
How many Phantom Stock Units does the ZBH director hold after this transaction?
After the March 31, 2026 grant of 308.711 Phantom Stock Units, Robert Hagemann’s reported balance under the plan totals 31,982.841 units. This figure reflects his entire phantom unit position directly held through the deferred compensation arrangement at that time.
How and when will the ZIMMER BIOMET (ZBH) Phantom Stock Units be settled?
The Phantom Stock Units will be settled in cash, not shares, in five annual installments. Payments begin within sixty days after the end of the calendar year in which Robert Hagemann’s service as a Zimmer Biomet director ceases, according to the plan’s terms.
What is the significance of the 87.178 Phantom Stock Units mentioned in the ZBH filing?
The 87.178 Phantom Stock Units were accrued on January 30, 2026 through the plan’s dividend reinvestment provision. This means phantom equivalents of dividends were reinvested into additional units, increasing Robert Hagemann’s deferred compensation balance linked to Zimmer Biomet’s common stock value.